Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that following the contract renewal with the China National Healthcare Security Administration (“NHSA”), the updated National ...
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback